PolyVascular, CobiCure partner on non-surgical pediatric heart valve
CobiCure Medical Technologies announced that it provided $2 million in funding to PolyVascular to advance a pediatric heart valve. Houston-based PolyVascular — a MedTech Innovator accelerator participant in 2020 — develops a first-of-its-kind heart valve. The potentially transformative, non-surgical valve... Read More →
TechCruch selects CellChorus for Startup Battlefield 200 at TechCrunch Disrupt
Fewer than 50 health and bio companies selected to present at TechCrunch event in San Francisco from September 19th to 21st HOUSTON, Texas — August 24, 2023 — CellChorus Inc. today announced that TechCrunch has selected CellChorus to present at... Read More →
Sparta Biomedical Celebrates Prestigious Recognition in MedTech and Significant Milestone
MORRISVILLE, N.C., Aug. 24, 2023 /PRNewswire/ — Sparta Biomedical Inc, a pioneering medical technology company specializing in redefining osteoarthritis treatment, proudly reflects on a momentous period marked by significant recognition and notable achievements. Sparta’s inclusion among the top 61 MedTech... Read More →
SG healthtech startup Neurowyzr secures additional $2.1m in Peak XV-led round
Neurowyzr, a Singapore-based health tech startup, has raised an additional $2.1 million in funding from Peak XV Partners, formerly known as Sequoia Capital India and SEA, and other investors, according to its filings with Singapore’s Accounting and Corporate Regulatory Authority... Read More →
Zetagen Therapeutics Secures 9.79 Million USD Series B Funding Raise for Advancement of ZetaMet™ and ZetaMAST™ for Treatment of Metastatic Bone and Soft Tissue Lesions
ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently in Phase 2a clinical trials for treatment of metastatic breast cancer lesions to bone as part of advanced stage cancer therapy.... Read More →
Scribe Biosciences Awarded a NIH Grant for High Throughput, Single-Cell Antibody Discovery
San Francisco, CA – August 10, 2023, Scribe Biosciences, a company developing technologies to study functional cell to cell interactions in a microenvironment, has announced it has received a NIH grant through the National Institute of Allergy and Infectious Disease... Read More →
RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization
RevBio has Developed a More Rapidly Resorbing Formulation of its Bone Adhesive Biomaterial for Implant Dentistry which will be Used in this Study LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration... Read More →
Navi Closes $2.4 Million Round for its Breakthrough Medical Device
Navi is pleased to announce the successful completion of its latest funding round, securing a total of $2.4 million. Investors who took part in this round of funding included a $700,000 lead investment from $2 billion investment fund Breakthrough Victoria,... Read More →
RealSeq Secures Seed Financing to Advance the RiboMarkerTM Diagnostic Platform
Next Gen RNA fragmentomics-based diagnostics SANTA CRUZ, CALIFORNIA, UNITED STATES, July 27, 2023/EINPresswire.com/ — RealSeq Biosciences, Inc., a company developing RNA fragmentomics as real-time diagnostics for disease, today announced the close of its oversubscribed seed round. The investment allows RealSeq... Read More →
CellChorus joins NVIDIA Inception
Program nurtures startups revolutionizing industries with advancements in artificial intelligence HOUSTON, Texas — July 25, 2022 — CellChorus Inc. today announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in artificial intelligence (AI)... Read More →